In recent years, cancer researchers have made major breakthroughs by using the body’s immune system to fight cancer. One of the most promising approaches, known as immune checkpoint blockade, works by releasing molecular “brakes” on T cells.
Cholesterol transporter ABCA1 boosts macrophage-driven cancer immunity
- Post author:admin
- Post published:February 7, 2026
- Post category:uncategorized